AI revolutionizes drug development in 2025, enhancing efficiency, reducing costs, and driving innovation in the Drug Development Pipeline Insights 2025.
Johnson & Johnson's acquisition of Intra-Cellular Therapies enhances its neuroscience portfolio with CAPLYTA® and a robust pipeline, addressing critical mental health needs.
Understand the importance of patent analysis in biotech investments to mitigate risks, secure market exclusivity, and identify innovation opportunities in 2025.
The impact of AI on drug discovery in 2025 is profound, reducing costs, accelerating timelines, and improving success rates in clinical trials and drug design.
Thermo Fisher cuts 300 jobs in viral vector manufacturing amid 2025 biopharma layoffs, driven by economic pressures, R&D shifts, and pipeline failures.
Vertex's non-opioid pain drug is approved by FDA, offering effective relief by targeting sodium channels, eliminating addiction risks and opioid side effects.
Meta's AI strategy evolves with a $65B investment by 2025, open-source models like Llama, and lessons from DeepSeek's cost-efficient AI breakthroughs.
How AI is revolutionizing IT market strategies in 2025 with hyper-personalization, edge AI, and automation driving innovation and operational efficiency.
New study highlights affordable alternatives to GLP-1 drugs for effective weight loss, including metformin, berberine, and sustainable lifestyle changes.
Twilio's financial growth and market expansion in 2025 drive a 20% stock surge. Analysts upgrade ratings, citing profitability and AI-driven strategies.